Global Sarcopenia Treatment Supplements Market Growth (Status and Outlook) 2023-2029

March 2023 | 104 pages | ID: G33982704A54EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

There is no approved treatment option available for sarcopenia treatment but nutrition and dietary supplements have a key role in sarcopenia treatment.Major Sarcopenia treatment supplement comprises of protein, amino acids, creatine, omega 3 acid, vitamin D and B12, calcium carbonate. Nutrition prevents accelerated muscle loss during a period of muscle disuse and maintains energy.

LPI (LP Information)' newest research report, the “Sarcopenia Treatment Supplements Industry Forecast” looks at past sales and reviews total world Sarcopenia Treatment Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Sarcopenia Treatment Supplements sales for 2023 through 2029. With Sarcopenia Treatment Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sarcopenia Treatment Supplements industry.

This Insight Report provides a comprehensive analysis of the global Sarcopenia Treatment Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sarcopenia Treatment Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sarcopenia Treatment Supplements market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sarcopenia Treatment Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sarcopenia Treatment Supplements.

The global Sarcopenia Treatment Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Sarcopenia Treatment Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Sarcopenia Treatment Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Sarcopenia Treatment Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Sarcopenia Treatment Supplements players cover Abbott Laboratories, Nestl?, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline and Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Sarcopenia Treatment Supplements market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Protein Supplements
  • Calcium Supplements
  • Others
Segmentation by application
  • Online Pharmacies
  • Retail Pharmacies
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott Laboratories
  • Nestl?
  • Pfizer
  • Amway
  • By-health
  • Usana
  • A&Z Pharmaceutical
  • GlaxoSmithKline
  • Bayer
  • H&H
  • Blackmores
  • Zhendong Group
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sarcopenia Treatment Supplements Market Size 2018-2029
  2.1.2 Sarcopenia Treatment Supplements Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Sarcopenia Treatment Supplements Segment by Type
  2.2.1 Protein Supplements
  2.2.2 Calcium Supplements
  2.2.3 Others
2.3 Sarcopenia Treatment Supplements Market Size by Type
  2.3.1 Sarcopenia Treatment Supplements Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
2.4 Sarcopenia Treatment Supplements Segment by Application
  2.4.1 Online Pharmacies
  2.4.2 Retail Pharmacies
2.5 Sarcopenia Treatment Supplements Market Size by Application
  2.5.1 Sarcopenia Treatment Supplements Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)

3 SARCOPENIA TREATMENT SUPPLEMENTS MARKET SIZE BY PLAYER

3.1 Sarcopenia Treatment Supplements Market Size Market Share by Players
  3.1.1 Global Sarcopenia Treatment Supplements Revenue by Players (2018-2023)
  3.1.2 Global Sarcopenia Treatment Supplements Revenue Market Share by Players (2018-2023)
3.2 Global Sarcopenia Treatment Supplements Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SARCOPENIA TREATMENT SUPPLEMENTS BY REGIONS

4.1 Sarcopenia Treatment Supplements Market Size by Regions (2018-2023)
4.2 Americas Sarcopenia Treatment Supplements Market Size Growth (2018-2023)
4.3 APAC Sarcopenia Treatment Supplements Market Size Growth (2018-2023)
4.4 Europe Sarcopenia Treatment Supplements Market Size Growth (2018-2023)
4.5 Middle East & Africa Sarcopenia Treatment Supplements Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Sarcopenia Treatment Supplements Market Size by Country (2018-2023)
5.2 Americas Sarcopenia Treatment Supplements Market Size by Type (2018-2023)
5.3 Americas Sarcopenia Treatment Supplements Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sarcopenia Treatment Supplements Market Size by Region (2018-2023)
6.2 APAC Sarcopenia Treatment Supplements Market Size by Type (2018-2023)
6.3 APAC Sarcopenia Treatment Supplements Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sarcopenia Treatment Supplements by Country (2018-2023)
7.2 Europe Sarcopenia Treatment Supplements Market Size by Type (2018-2023)
7.3 Europe Sarcopenia Treatment Supplements Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sarcopenia Treatment Supplements by Region (2018-2023)
8.2 Middle East & Africa Sarcopenia Treatment Supplements Market Size by Type (2018-2023)
8.3 Middle East & Africa Sarcopenia Treatment Supplements Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SARCOPENIA TREATMENT SUPPLEMENTS MARKET FORECAST

10.1 Global Sarcopenia Treatment Supplements Forecast by Regions (2024-2029)
  10.1.1 Global Sarcopenia Treatment Supplements Forecast by Regions (2024-2029)
  10.1.2 Americas Sarcopenia Treatment Supplements Forecast
  10.1.3 APAC Sarcopenia Treatment Supplements Forecast
  10.1.4 Europe Sarcopenia Treatment Supplements Forecast
  10.1.5 Middle East & Africa Sarcopenia Treatment Supplements Forecast
10.2 Americas Sarcopenia Treatment Supplements Forecast by Country (2024-2029)
  10.2.1 United States Sarcopenia Treatment Supplements Market Forecast
  10.2.2 Canada Sarcopenia Treatment Supplements Market Forecast
  10.2.3 Mexico Sarcopenia Treatment Supplements Market Forecast
  10.2.4 Brazil Sarcopenia Treatment Supplements Market Forecast
10.3 APAC Sarcopenia Treatment Supplements Forecast by Region (2024-2029)
  10.3.1 China Sarcopenia Treatment Supplements Market Forecast
  10.3.2 Japan Sarcopenia Treatment Supplements Market Forecast
  10.3.3 Korea Sarcopenia Treatment Supplements Market Forecast
  10.3.4 Southeast Asia Sarcopenia Treatment Supplements Market Forecast
  10.3.5 India Sarcopenia Treatment Supplements Market Forecast
  10.3.6 Australia Sarcopenia Treatment Supplements Market Forecast
10.4 Europe Sarcopenia Treatment Supplements Forecast by Country (2024-2029)
  10.4.1 Germany Sarcopenia Treatment Supplements Market Forecast
  10.4.2 France Sarcopenia Treatment Supplements Market Forecast
  10.4.3 UK Sarcopenia Treatment Supplements Market Forecast
  10.4.4 Italy Sarcopenia Treatment Supplements Market Forecast
  10.4.5 Russia Sarcopenia Treatment Supplements Market Forecast
10.5 Middle East & Africa Sarcopenia Treatment Supplements Forecast by Region (2024-2029)
  10.5.1 Egypt Sarcopenia Treatment Supplements Market Forecast
  10.5.2 South Africa Sarcopenia Treatment Supplements Market Forecast
  10.5.3 Israel Sarcopenia Treatment Supplements Market Forecast
  10.5.4 Turkey Sarcopenia Treatment Supplements Market Forecast
  10.5.5 GCC Countries Sarcopenia Treatment Supplements Market Forecast
10.6 Global Sarcopenia Treatment Supplements Forecast by Type (2024-2029)
10.7 Global Sarcopenia Treatment Supplements Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Sarcopenia Treatment Supplements Product Offered
  11.1.3 Abbott Laboratories Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Nestl?
  11.2.1 Nestl? Company Information
  11.2.2 Nestl? Sarcopenia Treatment Supplements Product Offered
  11.2.3 Nestl? Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Nestl? Main Business Overview
  11.2.5 Nestl? Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Sarcopenia Treatment Supplements Product Offered
  11.3.3 Pfizer Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Amway
  11.4.1 Amway Company Information
  11.4.2 Amway Sarcopenia Treatment Supplements Product Offered
  11.4.3 Amway Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Amway Main Business Overview
  11.4.5 Amway Latest Developments
11.5 By-health
  11.5.1 By-health Company Information
  11.5.2 By-health Sarcopenia Treatment Supplements Product Offered
  11.5.3 By-health Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 By-health Main Business Overview
  11.5.5 By-health Latest Developments
11.6 Usana
  11.6.1 Usana Company Information
  11.6.2 Usana Sarcopenia Treatment Supplements Product Offered
  11.6.3 Usana Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Usana Main Business Overview
  11.6.5 Usana Latest Developments
11.7 A&Z Pharmaceutical
  11.7.1 A&Z Pharmaceutical Company Information
  11.7.2 A&Z Pharmaceutical Sarcopenia Treatment Supplements Product Offered
  11.7.3 A&Z Pharmaceutical Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 A&Z Pharmaceutical Main Business Overview
  11.7.5 A&Z Pharmaceutical Latest Developments
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Information
  11.8.2 GlaxoSmithKline Sarcopenia Treatment Supplements Product Offered
  11.8.3 GlaxoSmithKline Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 GlaxoSmithKline Main Business Overview
  11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer Sarcopenia Treatment Supplements Product Offered
  11.9.3 Bayer Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 H&H
  11.10.1 H&H Company Information
  11.10.2 H&H Sarcopenia Treatment Supplements Product Offered
  11.10.3 H&H Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 H&H Main Business Overview
  11.10.5 H&H Latest Developments
11.11 Blackmores
  11.11.1 Blackmores Company Information
  11.11.2 Blackmores Sarcopenia Treatment Supplements Product Offered
  11.11.3 Blackmores Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Blackmores Main Business Overview
  11.11.5 Blackmores Latest Developments
11.12 Zhendong Group
  11.12.1 Zhendong Group Company Information
  11.12.2 Zhendong Group Sarcopenia Treatment Supplements Product Offered
  11.12.3 Zhendong Group Sarcopenia Treatment Supplements Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Zhendong Group Main Business Overview
  11.12.5 Zhendong Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Sarcopenia Treatment Supplements Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Protein Supplements
Table 3. Major Players of Calcium Supplements
Table 4. Major Players of Others
Table 5. Sarcopenia Treatment Supplements Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Sarcopenia Treatment Supplements Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Table 8. Sarcopenia Treatment Supplements Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Sarcopenia Treatment Supplements Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Table 11. Global Sarcopenia Treatment Supplements Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Sarcopenia Treatment Supplements Revenue Market Share by Player (2018-2023)
Table 13. Sarcopenia Treatment Supplements Key Players Head office and Products Offered
Table 14. Sarcopenia Treatment Supplements Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sarcopenia Treatment Supplements Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Sarcopenia Treatment Supplements Market Size Market Share by Regions (2018-2023)
Table 19. Global Sarcopenia Treatment Supplements Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Sarcopenia Treatment Supplements Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Sarcopenia Treatment Supplements Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Sarcopenia Treatment Supplements Market Size Market Share by Country (2018-2023)
Table 23. Americas Sarcopenia Treatment Supplements Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Table 25. Americas Sarcopenia Treatment Supplements Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Table 27. APAC Sarcopenia Treatment Supplements Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Sarcopenia Treatment Supplements Market Size Market Share by Region (2018-2023)
Table 29. APAC Sarcopenia Treatment Supplements Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Table 31. APAC Sarcopenia Treatment Supplements Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Table 33. Europe Sarcopenia Treatment Supplements Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Sarcopenia Treatment Supplements Market Size Market Share by Country (2018-2023)
Table 35. Europe Sarcopenia Treatment Supplements Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Table 37. Europe Sarcopenia Treatment Supplements Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Sarcopenia Treatment Supplements Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Sarcopenia Treatment Supplements Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Sarcopenia Treatment Supplements Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Sarcopenia Treatment Supplements Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Sarcopenia Treatment Supplements
Table 46. Key Market Challenges & Risks of Sarcopenia Treatment Supplements
Table 47. Key Industry Trends of Sarcopenia Treatment Supplements
Table 48. Global Sarcopenia Treatment Supplements Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Sarcopenia Treatment Supplements Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Sarcopenia Treatment Supplements Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Sarcopenia Treatment Supplements Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Abbott Laboratories Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 53. Abbott Laboratories Sarcopenia Treatment Supplements Product Offered
Table 54. Abbott Laboratories Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. Nestl? Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 58. Nestl? Sarcopenia Treatment Supplements Product Offered
Table 59. Nestl? Main Business
Table 60. Nestl? Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Nestl? Latest Developments
Table 62. Pfizer Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 63. Pfizer Sarcopenia Treatment Supplements Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Pfizer Latest Developments
Table 67. Amway Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 68. Amway Sarcopenia Treatment Supplements Product Offered
Table 69. Amway Main Business
Table 70. Amway Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Amway Latest Developments
Table 72. By-health Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 73. By-health Sarcopenia Treatment Supplements Product Offered
Table 74. By-health Main Business
Table 75. By-health Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. By-health Latest Developments
Table 77. Usana Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 78. Usana Sarcopenia Treatment Supplements Product Offered
Table 79. Usana Main Business
Table 80. Usana Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Usana Latest Developments
Table 82. A&Z Pharmaceutical Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 83. A&Z Pharmaceutical Sarcopenia Treatment Supplements Product Offered
Table 84. A&Z Pharmaceutical Main Business
Table 85. A&Z Pharmaceutical Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. A&Z Pharmaceutical Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 88. GlaxoSmithKline Sarcopenia Treatment Supplements Product Offered
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. GlaxoSmithKline Latest Developments
Table 92. Bayer Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 93. Bayer Sarcopenia Treatment Supplements Product Offered
Table 94. Bayer Main Business
Table 95. Bayer Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Bayer Latest Developments
Table 97. H&H Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 98. H&H Sarcopenia Treatment Supplements Product Offered
Table 99. H&H Main Business
Table 100. H&H Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. H&H Latest Developments
Table 102. Blackmores Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 103. Blackmores Sarcopenia Treatment Supplements Product Offered
Table 104. Blackmores Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Blackmores Main Business
Table 106. Blackmores Latest Developments
Table 107. Zhendong Group Details, Company Type, Sarcopenia Treatment Supplements Area Served and Its Competitors
Table 108. Zhendong Group Sarcopenia Treatment Supplements Product Offered
Table 109. Zhendong Group Main Business
Table 110. Zhendong Group Sarcopenia Treatment Supplements Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Zhendong Group Latest Developments

LIST OF FIGURES

Figure 1. Sarcopenia Treatment Supplements Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sarcopenia Treatment Supplements Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Sarcopenia Treatment Supplements Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Sarcopenia Treatment Supplements Sales Market Share by Country/Region (2022)
Figure 8. Sarcopenia Treatment Supplements Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Sarcopenia Treatment Supplements Market Size Market Share by Type in 2022
Figure 10. Sarcopenia Treatment Supplements in Online Pharmacies
Figure 11. Global Sarcopenia Treatment Supplements Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 12. Sarcopenia Treatment Supplements in Retail Pharmacies
Figure 13. Global Sarcopenia Treatment Supplements Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Global Sarcopenia Treatment Supplements Market Size Market Share by Application in 2022
Figure 15. Global Sarcopenia Treatment Supplements Revenue Market Share by Player in 2022
Figure 16. Global Sarcopenia Treatment Supplements Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Sarcopenia Treatment Supplements Market Size 2018-2023 ($ Millions)
Figure 18. APAC Sarcopenia Treatment Supplements Market Size 2018-2023 ($ Millions)
Figure 19. Europe Sarcopenia Treatment Supplements Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Sarcopenia Treatment Supplements Market Size 2018-2023 ($ Millions)
Figure 21. Americas Sarcopenia Treatment Supplements Value Market Share by Country in 2022
Figure 22. United States Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Sarcopenia Treatment Supplements Market Size Market Share by Region in 2022
Figure 27. APAC Sarcopenia Treatment Supplements Market Size Market Share by Type in 2022
Figure 28. APAC Sarcopenia Treatment Supplements Market Size Market Share by Application in 2022
Figure 29. China Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Sarcopenia Treatment Supplements Market Size Market Share by Country in 2022
Figure 36. Europe Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Figure 37. Europe Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Figure 38. Germany Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Sarcopenia Treatment Supplements Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Sarcopenia Treatment Supplements Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Sarcopenia Treatment Supplements Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Sarcopenia Treatment Supplements Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 52. APAC Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 53. Europe Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 55. United States Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 56. Canada Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 59. China Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 60. Japan Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 61. Korea Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 63. India Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 64. Australia Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 65. Germany Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 66. France Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 67. UK Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 68. Italy Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 69. Russia Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 70. Spain Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 73. Israel Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Sarcopenia Treatment Supplements Market Size 2024-2029 ($ Millions)
Figure 76. Global Sarcopenia Treatment Supplements Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Sarcopenia Treatment Supplements Market Size Market Share Forecast by Application (2024-2029)


More Publications